Regulations/Policies - Page 23 of 25 - Express Pharma

Industry recommends changes in draft guidelines for discontinuation of scheduled formulations

Punjab FDA restricts sale of bulk packs of products with high alcohol content

Centre clarifies reasons for delay in approvals for remdesivir

Industry welcomes draft New Drugs and Clinical Trials (Amendment) Rules

Telangana DCA issues approx 110 licenses for manufacturing hand sanitisers

Ministry of Health publishes draft New Drugs and Clinical Trials (Amendment) Rules

DoP issues brief guidelines for bulk drug parks, a detailed one to follow

Office of PSA, DST initiate consultation process for new Science, Technology, and Innovation Policy

High-level panel to recommend reforms in India’s drug regulations

Government identifies pharma as a champion sector